Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Camanni

Showing results (151-160 of 228) with videos related to

Pageof 23
Sort By:
Panminerva Medica|January 1, 1981
Approach to the diagnosis of hyperprolactinemic states: the nomifensine and domperidone testsG M Molinatti, F Camanni, D Cocchi, et al.
Peptides|January 1, 1997
Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRHE Arvat, L di Vito, B Maccagno, et al.
European Journal of Endocrinology|November 18, 2000
Interaction between glucagon and hexarelin, a peptidyl GH secretagogue, on somatotroph and corticotroph secretion in humansE Arvat, B Maccagno, J Ramunni, et al.
Neuroendocrinology|November 1, 1981
Effect of two indirectly acting dopamine agonists on prolactin secretion in normo- and hyperprolactinemic subjects: comparison with the effect of nomifensineF Camanni, A R Genazzani, V de Leo, et al.
Journal of Neuroendocrinology|February 14, 2009
Effects of alpha- and Beta-adrenergic agonists and antagonists on growth hormone secretion in manE Ghigo, J Bellone, E Arvat, et al.
Journal of Endocrinological Investigation|December 31, 1997
Long-term treatment with cabergoline, a new long-lasting ergoline derivate, in idiopathic or tumorous hyperprolactinaemia and outcome of drug-induced pregnancyE Ciccarelli, S Grottoli, P Razzore, et al.
Biological Psychiatry|March 12, 1998
Effects of beta-adrenergic agonists and antagonists on the growth hormone response to growth hormone-releasing hormone in anorexia nervosaL Gianotti, E Arvat, M R Valetto, et al.
The Journal of Endocrinology|May 1, 1988
Involvement of the somatostatin and cholinergic systems in the mechanism of growth hormone autofeedback regulation in the ratA Torsello, G Panzeri, P Cermenati, et al.
Life Sciences|August 31, 1981
Dopamine-mimetic and antagonist drugs: diagnostic and therapeutic applications in endocrine disordersE E Müller, F Camanni, A R Genazzani, et al.
The American Journal of Physiology|June 11, 1999
Dose-response study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and womenE Ghigo, G Aimaretti, M Maccario, et al.
Pageof 23

Showing results (151-160 of 228) with videos related to

Sort By:
Pageof 23
Panminerva Medica|January 1, 1981
Approach to the diagnosis of hyperprolactinemic states: the nomifensine and domperidone testsG M Molinatti, F Camanni, D Cocchi, et al.
Peptides|January 1, 1997
Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRHE Arvat, L di Vito, B Maccagno, et al.
European Journal of Endocrinology|November 18, 2000
Interaction between glucagon and hexarelin, a peptidyl GH secretagogue, on somatotroph and corticotroph secretion in humansE Arvat, B Maccagno, J Ramunni, et al.
Neuroendocrinology|November 1, 1981
Effect of two indirectly acting dopamine agonists on prolactin secretion in normo- and hyperprolactinemic subjects: comparison with the effect of nomifensineF Camanni, A R Genazzani, V de Leo, et al.
Journal of Neuroendocrinology|February 14, 2009
Effects of alpha- and Beta-adrenergic agonists and antagonists on growth hormone secretion in manE Ghigo, J Bellone, E Arvat, et al.
Journal of Endocrinological Investigation|December 31, 1997
Long-term treatment with cabergoline, a new long-lasting ergoline derivate, in idiopathic or tumorous hyperprolactinaemia and outcome of drug-induced pregnancyE Ciccarelli, S Grottoli, P Razzore, et al.
Biological Psychiatry|March 12, 1998
Effects of beta-adrenergic agonists and antagonists on the growth hormone response to growth hormone-releasing hormone in anorexia nervosaL Gianotti, E Arvat, M R Valetto, et al.
The Journal of Endocrinology|May 1, 1988
Involvement of the somatostatin and cholinergic systems in the mechanism of growth hormone autofeedback regulation in the ratA Torsello, G Panzeri, P Cermenati, et al.
Life Sciences|August 31, 1981
Dopamine-mimetic and antagonist drugs: diagnostic and therapeutic applications in endocrine disordersE E Müller, F Camanni, A R Genazzani, et al.
The American Journal of Physiology|June 11, 1999
Dose-response study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and womenE Ghigo, G Aimaretti, M Maccario, et al.
Pageof 23